Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBIDOPA\LEVODOPA Cause Product use issue? 353 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 353 reports of Product use issue have been filed in association with CARBIDOPA\LEVODOPA. This represents 0.6% of all adverse event reports for CARBIDOPA\LEVODOPA.

353
Reports of Product use issue with CARBIDOPA\LEVODOPA
0.6%
of all CARBIDOPA\LEVODOPA reports
25
Deaths
105
Hospitalizations

How Dangerous Is Product use issue From CARBIDOPA\LEVODOPA?

Of the 353 reports, 25 (7.1%) resulted in death, 105 (29.7%) required hospitalization, and 4 (1.1%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBIDOPA\LEVODOPA. However, 353 reports have been filed with the FAERS database.

What Other Side Effects Does CARBIDOPA\LEVODOPA Cause?

Fall (7,132) Death (5,403) Dyskinesia (5,368) Tremor (3,689) General physical health deterioration (3,636) On and off phenomenon (3,509) Hallucination (3,367) Drug ineffective (3,205) Parkinson's disease (3,140) Device dislocation (2,937)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which CARBIDOPA\LEVODOPA Alternatives Have Lower Product use issue Risk?

CARBIDOPA\LEVODOPA vs CARBIMAZOLE CARBIDOPA\LEVODOPA vs CARBOCYSTEINE CARBIDOPA\LEVODOPA vs CARBOMER CARBIDOPA\LEVODOPA vs CARBON DIOXIDE CARBIDOPA\LEVODOPA vs CARBON MONOXIDE

Related Pages

CARBIDOPA\LEVODOPA Full Profile All Product use issue Reports All Drugs Causing Product use issue CARBIDOPA\LEVODOPA Demographics